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Objective: Because adynamic cardiomyoplasty, or wrapping skeletal muscle
around the heart, had been shown to provide a girdling effect and delay
progressive ventricular dilatation in heart failure, a similar girdling effect
by the much simpler procedure of cardiac binding, using a prosthetic
membrane to wrap the heart, was studied and compared with that of
adynamic cardiomyoplasty. Methods: Twenty-one dogs were divided into
control, adynamic cardiomyoplasty, and cardiac binding groups. Cardiac
dimension and hemodynamic studies were carried out before and 4 weeks
after rapid pacing at 250 beats/min. For adynamic cardiomyoplasty, the left
latissimus dorsi muscle was used for the cardiac wrap; for cardiac binding,
a Marlex sheet (C. R. Bard, Inc., Murray Hill, N.J.) was used. Serial
two-dimensional echocardiography, right heart catheterization, and in the
cardiac binding group, left heart catheterization were performed. Results:
Four weeks of rapid pacing induced severe heart failure and cardiac
dilatation. The magnitude of ventricular dilatation at the end of rapid
pacing was less in the cardiac binding group than in the control group and
least in the adynamic cardiomyoplasty group. Left ventricular end-diastolic
volume, end-systolic volume, and ejection fraction were 82.1 6 21.1 ml,
67.1 6 16.0 ml, and 17.5% 6 5.8%, respectively, in the control group; 61.9.
6 8.1 ml, 44.1 6 7.8 ml, and 30.1% 6 3.6%, respectively, in the cardiac
binding group; and 51.8 6 8.7 ml, 30.3 6 10.4 ml, and 27.0% 6 4.0%,
respectively, in the adynamic cardiomyoplasty group. Conclusions: Both
adynamic cardiomyoplasty and cardiac binding reduced cardiac enlarge-
ment and functional deterioration after rapid pacing, with adynamic
cardiomyoplasty appearing to be more effective, perhaps because of the
adaptive capabilities of the skeletal muscle wrap. However, cardiac binding
is a simpler and less invasive procedure, which may be useful as an adjunct
to prevent or delay progressive ventricular dilatation in heart failure.
(J Thorac Cardiovasc Surg 1998;116:148-53)
Surgical reduction of cardiac size to improve heartfailure in patients with dilated cardiomyopathy is
being popularized by Batista and associates1 with
the partial ventriculectomy operation. Although
early increase in ejection fraction has been noted in
many surviving patients,2, 3 the long-term outcome
after this operation is still unknown. One of the
concerns is the progressive redilatation of the ven-
tricle. It is reasonable to speculate that measures to
prevent or delay such progression of ventricular
dilatation could be helpful. We suggest that a “car-
diac binding procedure” may be useful for this
purpose.
Our concept of using prosthetic material to wrap
around the ventricles to reduce ventricular dilata-
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tion in a failing heart is an offshoot from our study
on the mechanisms of dynamic cardiomyoplasty, a
procedure that is currently undergoing a phase III
prospective randomized clinical trial.5 These studies
have shown that although dynamic contractions of
skeletal muscle wrapped around the ventricles in
synchrony with cardiac systole can reduce myocar-
dial stress and may improve systolic function, the
passive, that is, adynamic, wrapping of the failing
ventricles with skeletal muscle may by itself reduce
the progression of ventricular dilatation.6 Such ob-
servation in adynamic cardiomyoplasty has been
called “the girdling effect.”7 To further elucidate the
mechanisms of the girdling effect, we compared
adynamic cardiomyoplasty with a cardiac binding
procedure. In the latter, a prosthetic membrane
such as Marlex mesh (C. R. Bard, Inc., Murray Hill,
N.J.) is used to wrap the ventricles. The effects of
these procedures in a canine model of rapid-pacing
heart failure were compared. The results indicate
that cardiac binding may have a role in the manage-
ment of selected patients with heart failure.
Materials and methods
Twenty-six mongrel dogs weighing 23 to 33 kg (mean
27.9 6 3.2 kg) were studied in accordance with the
Guidelines of the Canadian Council for Animal Care. The
animals were randomly allocated into three groups. Five
dogs were eliminated from final data analyses for the
following reasons: Two (one each in the adynamic cardio-
myoplasty and cardiac binding groups) had faulty, improp-
erly pacing pacemakers; two (one each in the adynamic
and binding groups) died suddenly of presumed arrhyth-
mias; and another in the binding group died of thrombo-
embolism after cardiac catheterization. In the control
group (n 5 7) a pacemaker was inserted 10 days before
the onset of rapid pacing. The rapid pacing was continued
for 4 weeks to induce severe heart failure. In the cardiac
binding group (n 5 7), the same protocol as that for the
control group was followed, except that both ventricles
were wrapped with Marlex mesh at the time of the
pacemaker implantation before rapid pacing. In the third
group, adynamic cardiomyoplasty (n 5 4) was carried out
by using the left latissimus dorsi muscle to wrap the heart.
In this group, the adynamic cardiomyoplasty procedure
was done 4 weeks before the onset of rapid pacing so that
the animals could recover from the more invasive proce-
dure and to allow the wrapped skeletal muscle to undergo
“conformational change,” as will be discussed later. Then
these animals also underwent 4 weeks of rapid pacing.
Cardiac binding. Anesthesia was induced with sodium
pentobarbital (30 mg/kg) and maintained with 1% isoflu-
rane and oxygen delivered by a mechanical ventilator
(Muffled Anesthesia Ventilator series 200, Intermed, Pen-
lon, United Kingdom). A median sternotomy was per-
formed for pacemaker insertion and for cardiac binding
with Bard Marlex mesh. A wide pericardiotomy was
carried out and the Marlex mesh was wrapped around
both ventricles below the atrioventricular groove, snugly
against the epicardium but without tension, and sewn to
itself anteriorly to complete the wrap.
Adynamic cardiomyoplasty. Under general anesthesia,
the left latissimus dorsi muscle was harvested with the
animal in the right lateral decubitus position. The distal
and proximal muscular tendinous attachments were di-
vided and the thoracodorsal neurovascular pedicle was
preserved. No cardiomyostimulator was implanted. The
muscle was then transposed into the left pleural cavity
through a minithoracotomy created by resection of the
second rib anteriorly. The proximal tendon was reattached
to the periosteum of the resected rib to anchor it in place,
taking care not to compromise the thoracodorsal nerve
and vessels. The incision was closed in layers. The animal
was then repositioned in the supine position and a median
sternotomy performed. A wide pericardiotomy was car-
ried out and a pacemaker for rapid pacing was implanted
as described earlier. After this, the left latissimus dorsi
muscle was retrieved from the pleural space and wrapped
Fig. 1. The cardiac binding (Marlex) and adynamic car-
diomyoplasty (ACMP) groups showed less end-diastolic
ventricular dilatations at the end of 4 weeks of rapid
pacing than the control group (p 5 0.041; p 5 0.017).
Fig. 2. The cardiac binding (Marlex) and adynamic car-
diomyoplasty (ACMP) groups showed less end-systolic
ventricular dilatation at the end of 4 weeks of rapid pacing
than the control group (p 5 0.007; p 5 0.001).
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snugly in a posterior clockwise direction around both
ventricular surfaces, but without excessive tension. The
muscle was sewn to the pericardium along the posterior
atrioventricular groove.8 The epicardial pacing lead would
be used for rapid pacing. The mediastinum was drained
and the sternum closed with wires. These animals were
allowed to recover for 4 weeks before rapid pacing was
initiated.
Induction of heart failure. Heart failure was induced
during the 4-week period of continuous rapid pacing with
a modified Medtronic 8329 pacemaker (Medtronic, Inc.,
Minneapolis, Minn.). The pacemaker was placed in the
subcutaneous pocket in the anterior abdominal wall, and
a Medtronic 5071 myocardial lead was placed near the
apex of the left ventricle. These pacemakers were pro-
grammed transcutaneously by telemetry to a rate of 250
beats/min with a Medtronic model 9710 programmer.
Hemodynamic studies. Cardiac dimensions were mea-
sured before and 4 weeks after the rapid pacing with a
two-dimensional transthoracic echocardiogram (model
77020 AC, Hewlett-Packard Company, Andover, Mass.)
with the animal under general anesthesia. Both end-
diastolic volume and end-systolic volume were measured
and ejection fraction was calculated. Other hemodynamic
data were obtained with Swan-Ganz pulmonary catheters
(Baxter Healthcare Corporation, Edwards Division, Santa
Ana, Calif.). The stroke volume was measured by the
thermodilution method (model 90303A, Space Labs Inc.,
Redmond, Wash.). Hemodynamic parameters measured
included central venous pressure, right ventricular pres-
sure, main pulmonary artery pressure, and pulmonary
capillary wedge pressure. Systemic blood pressure was
monitored with a femoral artery catheter. The left side of
the heart was catheterized with a 5F pigtail catheter
(Selector, Namic Corp., Glens Falls, N.Y.) for the cardiac
binding group, specifically to rule out the possibility of
constrictions around the heart. During the catheteriza-
tion, the left ventricular end-diastolic pressure and rate of
left ventricular pressure rise were measured.
Each measurement was repeated three times. Statistical
analysis was carried out by means of SPSS version 7.5
(SPSS, Inc., Chicago, Ill.) with multivariate analysis of
variance, treating two time points (baseline and failure) as
repeated measures, in conjunction with the Scheffe test to
compare the differences between the cardiac binding and
adynamic cardiomyoplasty groups. The data were ex-
pressed as mean 6 standard deviation.
Results
Changes in cardiac dimensions measured by echo-
cardiography are shown in Figs. 1 to 3. All three
groups of animals had similar baseline values just
before the start of rapid pacing. Four weeks of such
rapid pacing resulted in severe heart failure in all
three groups as reflected in increases in pulmonary
capillary wedge pressure when compared with the
baseline (control, p , 0.001; adynamic cardiomyo-
plasty, p 5 0.012; binding, p 5 0.014) (Fig. 4),
decreases in ejection fraction and stroke volume,
and enlargement of ventricular volumes in both
systole and diastole. The magnitude of ventricular
dilatation at the end of the rapid pacing phase was
less in the cardiac binding (Marlex mesh) and
adynamic cardiomyoplasty groups than in the con-
trol group. Left ventricular end-diastolic and end-
systolic volumes in the cardiac binding group were
61.9 6 8.1 ml (p 5 0.041) and 44.1 6 7.8 ml (p 5
0.007), respectively, compared with 82.1 6 21.1 ml
and 67.1 6 16.0 ml, respectively, in the control
group. Similarly, in the adynamic cardiomyoplasty
group, left ventricular end-diastolic and end-systolic
volumes were 51.8 6 8.7 ml (p 5 0.017) and 30.3 6
10.4 ml (p 5 0.001), respectively. Left ventricular
ejection fractions were higher in the cardiac binding
and adynamic cardiomyoplasty groups than in the
control group. Left ventricular ejection fractions in
the cardiac binding and adynamic cardiomyoplasty
Fig. 3. Ejection fractions decreased at the end of rapid
pacing in all groups. The cardiac binding (Marlex) and
adynamic cardiomyoplasty (ACMP) groups have higher
values than the control group (p 5 0.015; p 5 0.001).
Fig. 4. Pulmonary capillary wedge pressures in all three
groups during heart failure were higher than baseline (p ,
0.001; p 5 0.014; p 5 0.012.) The differences among the
groups did not reach statistical significance.
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groups were 30.1% 6 3.6% (p 5 0.001) and 27.0%
6 4.0% (p 5 0.015), respectively, compared with
17.5% 6 5.8% in the control group at the end of the
rapid pacing phase.
Lack of equalization of mean left ventricular
end-diastolic pressure (21 6 4.6 mm Hg) with right
ventricular end-diastolic pressure (15.3 6 1.3 mm
Hg) in four selected animals subjected to cardiac
binding during the heart failure period suggested no
evidence of constrictive restrictions by the Marlex
mesh around the heart. However, the statistical
power for this observation is limited by the small
sample size.
Discussion
As stated earlier, this study was originally initiated
to further elucidate the mechanisms of the dynamic
cardiomyoplasty procedure. Use of dynamic cardio-
myoplasty to treat heart failure has undergone
phase I and phase II clinical trials, and a phase III
prospective randomized study is in progress in
North America. Dynamic cardiomyoplasty alleviates
the symptoms of moderate to severe heart failure
and improves the functional capacity and the quality
of life in most treated patients, but hemodynamic
changes are modest.5 These findings have led to
renewed investigation on the possible underlying
mechanisms of dynamic cardiomyoplasty.6 Systolic
squeeze is the originally proposed, and still impor-
tant, mechanism of dynamic cardiomyoplasty. For
example, recently a new technique in which a bal-
loon was placed in the interface between the skeletal
muscle wrap and the epicardium demonstrated that
the transmyocardial pressure gradient decreased in
dynamic cardiomyoplasty when the wrapped muscle
was stimulated to contract in synchrony with cardiac
systole.10 This leads to reduced wall stress during
systole, known as the “myocardial sparing effect.”
However, long-term follow-ups of these patients
indicate that there may be other additional effects of
cardiomyoplasty. Serial radiographic studies show
that in many patients the cardiothoracic ratio stabi-
lized,11 which is confirmed by echocardiography and
by ventricular pressure-volume loops obtained with
conductance catheters. In some patients, the cardiac
size appeared to decrease over time, which was
described as “reverse remodeling” by Kass and
colleagues.12 Of particular interest was the observa-
tion that in one of their patients, despite the lack of
demonstrable contraction of the wrapped muscle,
perhaps owing to technical problems, the modula-
tion of the myocardial remodeling process seen in
heart failure appeared to take place in the presence
of the passive muscle wrap, that is, “adynamic
cardiomyoplasty.”
A series of experiments carried out by Capouya
and coworkers7 and by our group13 confirmed that
adynamic cardiomyoplasty can delay ventricular di-
latation and sustain ejection fraction in a canine
model of rapid-pacing heart failure. Rapid pacing is
a well-defined experimental model that leads to
severe dilated cardiomyopathy and heart failure in 3
to 4 weeks.14
How can the passive presence of wrapped skeletal
muscle prevent cardiac dilatation without constric-
tion? The pericardial sac is known to restrict acute
cardiac dilatation such as that induced by a rapid
increase in preload. However, it shows virtually no
restraining effect on chronic cardiac dilatation. It
was proposed that elastic stretchability of the skel-
etal muscle allowed it to provide dynamic constraint
against progressive cardiac dilatation.12 We there-
fore attempted to compare adynamic cardiomyo-
plasty with cardiac binding using Marlex mesh,
which does not share such characteristics of the
skeletal muscle wrap.
Vaynblat and associates15 studied the cardiac
binding effect with polytetrafluoroethylene* in a
canine model of doxorubicin-induced heart failure
and showed that cardiac binding reduced ventricular
dilatation, as we saw in our animals. They did not
demonstrate improvement in cardiac function. We
also observed better preservation of ventricular vol-
ume in the cardiac binding and adynamic cardiomy-
oplasty animals compared with that in the control
group. In addition, we found that ejection fraction
was better preserved with adynamic cardiomyo-
plasty and cardiac binding with Marlex mesh than in
the control group. Although not always reaching
statistical significance owing to the relatively small
sample size, our data indicate a trend that the effects
of cardiac binding with Marlex mesh on changes in
cardiac dimensions and ejection fraction may be
between those observed in the control and in the
adynamic cardiomyoplasty groups. Marlex mesh is a
synthetic knitted polypropylene monofilament that
can stretch somewhat in both directions and induces
more fibrotic responses than the polytetrafluoroeth-
ylene membrane. Skeletal muscle flap used for
adynamic cardiomyoplasty is certainly much more
stretchable than these prosthetic membranes. We
*Gore-Tex graft, registered trade name of W. L. Gore &
Associates, Inc., Elkton, Md.
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were therefore concerned about the possibility of
pericardial constrictions by Marlex mesh and epicar-
dial fibrosis. Thus we carried out left heart cathe-
terization in the cardiac binding group. Our findings
of lack of equalization between left and right ven-
tricular end-diastolic pressures in the animals stud-
ied suggest that there were no significant restrictions
to their ventricular filling. Finally, the mean pulmo-
nary capillary wedge pressures were slightly higher
in the cardiac binding group than in the other
groups, but this difference did not reach statistical
significance. The apparent difference in pulmonary
capillary wedge pressure may also reflect some
variation in volume status in each animal at the time
of study.
Although cardiac binding with Marlex mesh dem-
onstrated its ability to reduce progressive cardiac
dilatation and deterioration in ejection fraction dur-
ing rapid pacing, the effects appeared to be less than
those observed with adynamic cardiomyoplasty. We
speculate that this is indeed due to the unique
characteristics of a living muscle tissue used for
cardiomyoplasty. A study on the passive stretch
properties of the canine diaphragm muscle suggests
a possible advantage for using muscle rather than
prosthetic material.16 The passive stress-stretch be-
havior of the muscle was nonlinear, with the muscle
getting stiffer as stretch increased. This ability to
both yield and support would be a unique advantage
in providing passive restraint against left ventricular
dilatation without significantly compromising dia-
stolic filling. In contrast, the fibrotic reaction in-
duced by Marlex mesh would provide minimal com-
pliance. In addition to the stretchability, skeletal
muscle is known to be able to undergo “conforma-
tional change,” adapting to chronic changes in rest-
ing tension by the addition or deletion of the
number of sarcomeres in the muscle fibers.17, 18 This
process allows for the skeletal muscle to restore
optimal resting tension, without altering the normal
dimension of individual sarcomere units. Although
it has not been possible to measure the resting
tension of the wrapped muscle per se, serial deter-
mination of the Frank-Starling curve in the skeletal
muscle ventricle has yielded data consistent with this
hypothesis.19 By being more versatile in adapting to
a changing dimension of the failing heart, cardiomy-
oplasty can be superior to a prosthetic wrap.
On the other hand, adynamic cardiomyoplasty is a
more invasive and complex surgical procedure than
cardiac binding with a prosthetic membrane. Dissec-
tion of the latissimus dorsi muscle may take 1 to 2
hours, usually done with the patient in the lateral
decubitus position. Additional time is required to
close and drain the wound and to reposition the
patient for sternotomy for the second stage of the
procedure, namely, the wrapping of the ventricles
with the muscle pedicle that had been inserted into
the left pleural cavity.8 In part because of such
invasiveness and the length of procedure required,
dynamic cardiomyoplasty is currently recommended
for patients in New York Heart Association Func-
tional class III, rather than in the more seriously ill
patients with class IV disease.5 In contrast, cardiac
binding is a much simpler procedure, which can be
carried out rapidly. The procedure lends itself
readily to the video-assisted thoracoscopic ap-
proach, which makes it even less invasive.
The main benefit of cardiac binding appears to be
the process of attenuating the deleterious ventricu-
lar remodeling process. Nevertheless, dynamic car-
diomyoplasty does offer the added advantage of
being able to induce reverse remodeling of dilated
cardiomyopathy, as demonstrated clinically.12, 20 We
believe that passive restraint against further dilata-
tion is not alone sufficient to reverse remodeling and
that this may necessitate the added benefit of active
systolic assist available through dynamic cardiomy-
oplasty. The role of cardiac binding in the surgical
management of heart failure instead may be as an
adjunct to other more definitive procedures, with
the simple goal of reducing subsequent progressive
dilatation of a failing heart. One such example is to
follow Batista’s partial ventriculectomy for dilated
cardiomyopathy with cardiac binding, thus prevent-
ing or delaying the redilatation of the heart.21
Although we did not detect deleterious side effects
of cardiac binding in this study, both the potential
complications and the clinical efficacy of cardiac
binding as an adjunct procedure in the management
of heart failure require further experimental and
clinical explorations.
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